Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Strategic Challenges | Learn about the company's navigation of product transitions and increased marketing spend, and their potential impact on profitability |
Market Valuation | Analyst price targets range from $101 to $260, with an average of $224, reflecting diverse views on Inspire Medical's growth potential |
Financial Crossroads | Delve into Inspire Medical's strong Q4 performance and 2025 guidance, balancing optimism with increased spending and market challenges |
Inspire V's Impact | Explore how Inspire Medical's latest product launch could drive growth and market leadership in the Hypoglossal Nerve Stimulation secto |

Metrics to compare | INSP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipINSPPeersSector | |
|---|---|---|---|---|
P/E Ratio | 11.2x | −15.7x | −0.5x | |
PEG Ratio | 0.06 | 0.13 | 0.00 | |
Price / Book | 2.1x | 2.6x | 2.6x | |
Price / LTM Sales | 1.8x | 1.6x | 3.2x | |
Upside (Analyst Target) | 23.2% | 35.3% | 47.6% | |
Fair Value Upside | Unlock | 5.1% | 6.1% | Unlock |